Benefiber ‘Helps Maintain Regularity’ Claim Fails NAD Review; Decision Appealed
This article was originally published in The Tan Sheet
Executive Summary
Novartis Health disagrees with the National Advertising Division decision that the Benefiber express claim “helps maintain regulatory” is not supported by research and will appeal the decision. NAD reviewed the claim made in a challenge by Metamucil fiber supplement marketer P&G.